Meissa Vaccines, Inc.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months (NCT04909021) | Meissa Vaccines, Inc. | 2021-06-03 |
| Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults (NCT04798001) | Meissa Vaccines, Inc. | 2021-04-12 |
| Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine (NCT04690335) | Meissa Vaccines, Inc. | 2020-12-29 |
| Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children (NCT04444284) | Meissa Vaccines, Inc. | 2020-06-09 |
| Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults (NCT04227210) | Meissa Vaccines, Inc. | 2020-01-14 |
Track Meissa Vaccines, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.